Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines

Leslie Jones, Shabbir Ahmad, Kenneth Chan, Paulo Verardi, William R. Morton, Richard Grant, Tilahun Yilma

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The only vaccines shown to be protective against intravenous challenge with virulent virus in the simian immunodeficiency virus (SIV)/macaque model are attenuated live SIVs. However, these vaccines have several disadvantages: 1) they persist indefinitely in vaccinated macaques; 2) they are pathogenic to neonatal macaques; and 3) they are lethal in some adult macaques. To enhance the safety and efficacy of these vaccines, we immunized macaques first with recombinant vaccines and then inoculated the animals with SIV (Δnef). In the first experiment, preimmunized macaques advanced to disease slower than controls after challenge with virulent SIV; five animals survived for 3 years without disease and only the vaccine virus (SIV(Δnef)) could be isolated at this time. In the second experiment, preimmunized animals had lower virus loads and no disease compared to controls. (C) Munksgaard, Copenhagen.

Original languageEnglish (US)
Pages (from-to)231-239
Number of pages9
JournalJournal of Medical Primatology
Volume29
Issue number3-4
StatePublished - 2000

Fingerprint

Simian immunodeficiency virus
Simian Immunodeficiency Virus
Synthetic Vaccines
Macaca
recombinant vaccines
Vaccines
vaccines
Safety
Viruses
viruses
viral load
laboratory animals
animals

Keywords

  • Attenuation
  • Live vaccines
  • Load
  • Macaques
  • Subunit
  • Virus

ASJC Scopus subject areas

  • Animal Science and Zoology
  • veterinary(all)

Cite this

Jones, L., Ahmad, S., Chan, K., Verardi, P., Morton, W. R., Grant, R., & Yilma, T. (2000). Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines. Journal of Medical Primatology, 29(3-4), 231-239.

Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines. / Jones, Leslie; Ahmad, Shabbir; Chan, Kenneth; Verardi, Paulo; Morton, William R.; Grant, Richard; Yilma, Tilahun.

In: Journal of Medical Primatology, Vol. 29, No. 3-4, 2000, p. 231-239.

Research output: Contribution to journalArticle

Jones, L, Ahmad, S, Chan, K, Verardi, P, Morton, WR, Grant, R & Yilma, T 2000, 'Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines', Journal of Medical Primatology, vol. 29, no. 3-4, pp. 231-239.
Jones, Leslie ; Ahmad, Shabbir ; Chan, Kenneth ; Verardi, Paulo ; Morton, William R. ; Grant, Richard ; Yilma, Tilahun. / Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines. In: Journal of Medical Primatology. 2000 ; Vol. 29, No. 3-4. pp. 231-239.
@article{076988f9f05f4839b4d795f22cb92e70,
title = "Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines",
abstract = "The only vaccines shown to be protective against intravenous challenge with virulent virus in the simian immunodeficiency virus (SIV)/macaque model are attenuated live SIVs. However, these vaccines have several disadvantages: 1) they persist indefinitely in vaccinated macaques; 2) they are pathogenic to neonatal macaques; and 3) they are lethal in some adult macaques. To enhance the safety and efficacy of these vaccines, we immunized macaques first with recombinant vaccines and then inoculated the animals with SIV (Δnef). In the first experiment, preimmunized macaques advanced to disease slower than controls after challenge with virulent SIV; five animals survived for 3 years without disease and only the vaccine virus (SIV(Δnef)) could be isolated at this time. In the second experiment, preimmunized animals had lower virus loads and no disease compared to controls. (C) Munksgaard, Copenhagen.",
keywords = "Attenuation, Live vaccines, Load, Macaques, Subunit, Virus",
author = "Leslie Jones and Shabbir Ahmad and Kenneth Chan and Paulo Verardi and Morton, {William R.} and Richard Grant and Tilahun Yilma",
year = "2000",
language = "English (US)",
volume = "29",
pages = "231--239",
journal = "Journal of Medical Primatology",
issn = "0047-2565",
publisher = "Blackwell Munksgaard",
number = "3-4",

}

TY - JOUR

T1 - Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines

AU - Jones, Leslie

AU - Ahmad, Shabbir

AU - Chan, Kenneth

AU - Verardi, Paulo

AU - Morton, William R.

AU - Grant, Richard

AU - Yilma, Tilahun

PY - 2000

Y1 - 2000

N2 - The only vaccines shown to be protective against intravenous challenge with virulent virus in the simian immunodeficiency virus (SIV)/macaque model are attenuated live SIVs. However, these vaccines have several disadvantages: 1) they persist indefinitely in vaccinated macaques; 2) they are pathogenic to neonatal macaques; and 3) they are lethal in some adult macaques. To enhance the safety and efficacy of these vaccines, we immunized macaques first with recombinant vaccines and then inoculated the animals with SIV (Δnef). In the first experiment, preimmunized macaques advanced to disease slower than controls after challenge with virulent SIV; five animals survived for 3 years without disease and only the vaccine virus (SIV(Δnef)) could be isolated at this time. In the second experiment, preimmunized animals had lower virus loads and no disease compared to controls. (C) Munksgaard, Copenhagen.

AB - The only vaccines shown to be protective against intravenous challenge with virulent virus in the simian immunodeficiency virus (SIV)/macaque model are attenuated live SIVs. However, these vaccines have several disadvantages: 1) they persist indefinitely in vaccinated macaques; 2) they are pathogenic to neonatal macaques; and 3) they are lethal in some adult macaques. To enhance the safety and efficacy of these vaccines, we immunized macaques first with recombinant vaccines and then inoculated the animals with SIV (Δnef). In the first experiment, preimmunized macaques advanced to disease slower than controls after challenge with virulent SIV; five animals survived for 3 years without disease and only the vaccine virus (SIV(Δnef)) could be isolated at this time. In the second experiment, preimmunized animals had lower virus loads and no disease compared to controls. (C) Munksgaard, Copenhagen.

KW - Attenuation

KW - Live vaccines

KW - Load

KW - Macaques

KW - Subunit

KW - Virus

UR - http://www.scopus.com/inward/record.url?scp=0033802478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033802478&partnerID=8YFLogxK

M3 - Article

C2 - 11085585

AN - SCOPUS:0033802478

VL - 29

SP - 231

EP - 239

JO - Journal of Medical Primatology

JF - Journal of Medical Primatology

SN - 0047-2565

IS - 3-4

ER -